[Federal Register Volume 62, Number 31 (Friday, February 14, 1997)]
[Notices]
[Page 7108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-3736]
[[Page 7107]]
_______________________________________________________________________
Part III
Department of Health and Human Services
_______________________________________________________________________
National Institutes of Health
_______________________________________________________________________
Recombinant DNA Advisory Committee Meeting and Recombinant DNA
Research: Proposed Actions Under the Guidelines; Notices
Federal Register / Vol. 62, No. 31 / Friday, February 14, 1997 /
Notices
[[Page 7108]]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Recombinant DNA Advisory Committee; Meeting
Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of
the Recombinant DNA Advisory Committee on March 6-7, 1997. The meeting
will be held at the National Institutes of Health, Building 31C, 6th
Floor, Conference Room 10, 9000 Rockville Pike, Bethesda, Maryland
20892, starting on March 6, 1997, at approximately 9 a.m., and will
recess at approximately 5 p.m. The meeting will reconvene on March 7,
1997, at approximately 8:30 a.m. and will adjourn at approximately 5
p.m. The meeting will be open to the public to discuss Proposed Actions
under the NIH Guidelines for Research Involving Recombinant DNA
Molecules (59 FR 34496) and other matters to be considered by the
Committee. The Proposed Actions to be discussed will follow this notice
of meeting. Attendance by the public will be limited to space
available. Members of the public wishing to speak at this meeting may
be given such opportunity at the discretion of the Chair.
Ms. Debra W. Knorr, Acting Director, Office of Recombinant DNA
Activities, National Institutes of Health, MSC 7010, 6000 Executive
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide materials to be discussed at
this meeting, roster of committee members, and substantive program
information. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should contact Ms. Knorr in advance of the meeting. A
summary of the meeting will be available at a later date.
OMB's ``Mandatory Information Requirements for Federal Assistance
Program Announcements'' (45 FR 39592, June 11, 1980) requires a
statement concerning the official government programs contained in the
Catalog of Federal Domestic Assistance. Normally NIH lists in its
announcements the number and title of affected individual programs for
the guidance of the public. Because the guidance in this notice covers
not only virtually every NIH program but also essentially every Federal
research program in which DNA recombinant molecule techniques could be
used, it has been determined not to be cost effective or in the public
interest to attempt to list these programs. Such a list would likely
require several additional pages. In addition, NIH could not be certain
that every Federal program would be included as many Federal agencies,
as well as private organizations, both national and international, have
elected to follow the NIH Guidelines. In lieu of the individual program
listing, NIH invites readers to direct questions to the information
address above about whether individual programs listed in the Catalog
of Federal Domestic Assistance are affected.
Dated: January 30, 1997.
Paula N. Hayes,
Acting Committee Management Officer, National Institutes of Health.
[FR Doc. 97-3736 Filed 2-12-97; 8:45 am]
BILLING CODE 4140-01-M
